Member Info for Matador78

https://www.prnewswire.com/news-releases/lygenesis-announces-four-peer-reviewed-publications-on-its-organ-regeneration-technology-301119357.html

LyGenesis' lead development asset is liver regeneration, which was the focus of the first two papers. Development of Ectopic Livers by Hepatocyte Transplantation into Swine Lymph Nodes by Fontes et al. was published this month in Liver Transplantation, demonstrating that functional mini-livers could be grown using the lymph node as a bioreactor. In this swine model using surgically-induced liver injuries, liver cells were isolated from the animals and then transplanted into lymph nodes in the abdominal region of the animal. In 100% of the animals the transplanted liver cells engrafted into the lymph nodes, proliferated, and formed ectopic mini-livers, which had the same structure and function as native liver tissue. The cell transplant procedure was safe, well tolerated, and as expected, the amount of liver mass generated by the ectopic livers was proportional to the degree of the native liver's damage.

The second paper, Ex Vivo Cell Therapy by Ectopic Hepatocyte Transplantation Treats Porcine Tyrosinemia Model of Acute Liver Failure by Nicolas and colleagues was published in Molecular Therapy: Methods & Clinical Developments. In this study, a human liver disease (tyrosinemia Type I) was modeled in swine, and liver cells transplanted into lymph nodes were capable of forming ectopic livers that cured all of the animals of otherwise fatal liver disease. The engraftments were again shown to be safe and also structurally and functionally similar to native liver tissue.

https://www.newswire.ca/news-releases/globalive-technology-reports-results-for-second-quarter-of-2020-864532603.html

FastForward Innovations Ltd is pleased to announce that the revised Chapter 11 Plan of Reorganization for investee company Factom, Inc. ('Factom'), which allows for FastForward's US$6 million SAFE note be converted to equity in Factom, has been approved by the United States Bankruptcy Court for the District of Delaware and shareholders of Factom. As a result, FastForward expects the conversion of the SAFE note will occur in the coming days and following this, the Company will hold 6,311,330 shares in Factom, representing 30.39% of the issued share capital.



Whilst the Company's interest in Factom has been written down to zero as announced on 14 April 2020, today's announcement forms part of continuing action by the Company to recover value for Shareholders from its investment in Factom. Further updates will follow in due course.



As announced on 30 July 2020, a provisional agreement ('the Agreement') was reached with Factom which proposed that FastForward's US$6 million SAFE note be converted to equity by the issue of 5,911,330 new shares in Factom. The Chapter 11 Plan of Reorganization was amended by Factom to reflect the Agreement and lodged with the Court on 30 July 2020. Following the confirmation hearing, the revised plan has now been approved by the United States Bankruptcy Court for the District of Delaware and shareholders of Factom.



This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

Old but Gold.

https://qz.com/626064/a-former-cia-analyst-explains-how-tech-companies-can-help-fight-terrorism/

"Factom Inc's reorganisation has been confirmed. Some technicalities remain, but Factom Inc. is basically out of Chapter 11 subchapter v reorganisation."

Silly Silly Sellers

Told you at 5p you made money

Told you at 6p you made money

Having to tell you again now is embarrassing to be honest especially after everything we've been telling you over the last 3 years has been crystalised and consolidated now by everyone from the top down.

In a months time. I'll refer you back to today when you're scrolling through the messages to see exactly what it was you missed.

Silly Silly Sellers

O'Donnell seriously lad. Give it a rest.

or were going to have to have you removed from the board for being annoying.

Click on the link and have a listen with your cup of tea.

https://twitter.com/Tat_TvamAsi/status/1298349098463105024

Ed McDermott, CEO of FastForward, commented:

"It is positive to hear that Portage has filed its financial statements ahead of its extension deadline. Reassuringly, the statements highlight that the company has a *** strong cash position,*** which was bolstered by its recent fundraise of $6.98 million, providing resources for the continued development of its portfolio over the coming 12 months.

Portage is on target to have three products in clinical testing by the end of this year despite the disruptions as a result of COVID-19, and we look forward to providing further updates as its pipeline of companies continue to advance."

NovelDrinks.com

told you about Novel about 2 Months ago : )

FFWD definitely doesn't need posters to increase the share price.

All that's needed is for people to take some time out to read the portfolio.

I'm still adding.

This stock will be remembered on AIM for years to come.

https://amp.ft.com/content/5cd14fbb-2f67-43a6-a0b9-78cee07b8b81?__twitter_impression=true

Ed McDermott, CEO of FastForward, commented: "Leap Gaming continues to go from strength to strength and we are delighted to see that it has entered into another agreement which will see its games distributed across Vivo's extensive footprint, further increasing Leap's global reach and market share. I look forward to providing further updates as this exciting asset continues to grow."

I have a strong feeling we have a very positive RNS inbound

This is very relevant for FFWD holders

https://www.bbc.co.uk/news/business-53844725

and TMALL Global

Both integral for YOOMA.

AS IF TO DRIVE THE POINT HOME

https://europeangaming.eu/portal/latest-news/2020/08/20/76405/1x2-network-integrates-its-games-with-singular/

https://www.allure.com/story/the-future-of-aging

Last year, according to an IMARC market research report, the "anti-aging" industry was worth an estimated $54.2 billion.

Its skin-care formulas and supplements and high-tech treatments (like cryo-saunas, that claim to slow tissue damage with subfreezing liquid nitrogen baths) might have a superficial impact on our bodies, but the real work happens at the cellular level. That's where scientists are targeting the hallmarks of aging to create therapies that extend "health span." "The main objective is to live healthier longer, and the side effect of that is you tend to live longer as well,"

Get a loan

Go on then Wadnob.

Lead by example!